Apr 24, 2026 08:30AM
Mar 4, 2026 03:00AM
Nov 12, 2025 06:02PM
Nov 4, 2025 04:01PM
Aug 13, 2025 04:31PM
Aug 13, 2025 04:31PM
Aug 13, 2025 04:15PM Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
Aug 6, 2025 08:00AM
Aug 6, 2025 08:00AM
May 7, 2025 04:58PM
May 7, 2025 04:45PM
May 2, 2025 08:30AM
May 2, 2025 08:30AM
Mar 26, 2025 06:34PM Alvotech Reports Record Results for 2024 and Provides Business Update
Feb 24, 2025 08:00AM
Nov 13, 2024 04:05PM
Oct 30, 2024 08:30AM
Aug 15, 2024 04:30PM
Aug 15, 2024 06:15AM
Aug 15, 2024 04:30AM
Aug 1, 2024 04:01PM Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET
Jul 22, 2024 06:31AM
Jul 22, 2024 06:30AM
Jul 1, 2024 05:46AM
Jul 1, 2024 05:10AM
May 13, 2024 08:00AM
May 13, 2024 08:00AM
Apr 16, 2024 05:54PM Teva Pharma (TEVA) and Teva (TEVA) Announce FDA Approval of SELARSDI
Apr 16, 2024 05:43PM
Apr 16, 2024 05:30PM
Mar 5, 2024 04:00PM
Feb 25, 2024 08:36PM
Feb 23, 2024 08:15PM
Feb 23, 2024 08:15PM
Nov 28, 2023 04:19PM Alvotech (ALVO) Misses Q3 EPS by 114c
Nov 28, 2023 04:15PM
Nov 21, 2023 08:00AM
Aug 22, 2023 09:15AM
Aug 6, 2023 09:00PM
Jul 31, 2023 09:00PM
Jun 30, 2023 09:00PM
Jun 19, 2023 09:00PM Bragar Eagel & Squire, P.C. Is Investigating C3.ai, Ascendis, Alvotech, and Shift4 and Encourages Investors to Contact the Firm
May 19, 2023 05:45AM
May 19, 2023 05:00AM
Mar 1, 2023 04:30PM
Feb 27, 2023 07:15PM
Feb 27, 2023 07:15PM
Feb 9, 2023 02:30AM
Feb 9, 2023 02:30AM EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
Dec 7, 2022 04:00AM

1,197,507 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All